Surveillance Snapshot: Contraceptive Use Trends from the Periodic Health Assessment Among Female Active Duty U.S. Sailors and Marines, 2018–2023

Image of 66680994. Birth control methods are self-reported during annual Periodic Health Assessments of active duty U.S. service members.

This Surveillance Snapshot highlights trends in birth control methods among female active duty U.S. sailors and marines. Birth control methods are self-reported during annual Periodic Health Assessments of active duty U.S. service members. This analysis captures data on birth control use including long-acting reversible contraceptives, short-acting reversible contraceptives, intrauterine devices, implants, barrier methods, emergency contraception, sterilization, fertility awareness, or lack of use among individuals not actively taking steps to prevent pregnancy. These findings offer insights into active duty females’ preferences and behaviors beyond clinical data and may inform Defense Health Agency policies for enhancing female force readiness.

FIGURE. Prevalence of Birth Control Method, Reported on Periodic Health Assessments, Active Duty Sailors and Marines, 2018–2023. This figure presents a graph of eight discrete lines of data along the horizontal, or x-, axis. The eight lines of data along the x axis chart specific birth control methods: LARC (or long-acting reversible contraception), infertility or sterilization, cycle tracking, SARC (or short-acting reversible contraception), condom use, pregnant or breastfeeding, same sex, and abstinence. Each line connects six data points, with each point representing an individual year during the surveillance period. The vertical, or y-, axis measures the percent of use for each method, in units of 5, from 0 to 40. LARC use increased noticeably in 2021 and 2022, with a slight decline in 2023, from approximately 20 percent in 2020 to around 30 percent in 2023. At the beginning of the surveillance period, SARC and condom use were the most prevalent, at 35 and 30 percent, respectively, but both declined markedly as LARC use rose; in 2023 SARC use was approximately 18 percent and condom use was just over 15 percent. All other methods remained relatively constant, with infertility or sterilization the fourth most common, at just under 10 percent. All other methods were consistently below five percent.

This analysis examined responses to question 22 on PHA DD Form 3204, versions 1 and 2, for calendar years 2018–2023.1 The population included active duty female sailors and marines, ages 18-52 years. Version 2 of the form was introduced in August 2021 and retained the contraceptive questioning structure of version 1, allowing women to select why they may not be taking steps to prevent pregnancy. Contraceptive variables and free-text responses were used to determine prevalence of LARCs, SARCs, and other pregnancy prevention methods, which included infertility or sterilization (of the service member or partner), condom use, abstinence, fertility awareness methods, and pregnancy or breastfeeding. Alternatively, respondents could select a response indicating that pregnancy prevention was not needed (e.g., same sex partner[s], intention to conceive).

Among all PHAs completed and certified with medical provider signature (n=277,633), only 24.3% (n=67,430) included responses to assessment items on contraceptive methods. Among women with a response indicating at least one birth control method during the study period, the Figure illustrates the distribution of birth control methods by type. Self-reported SARC and condom use decreased from 34.6% to 18.1%, and 30.1% to 15.5%, respectively, from 2018 to 2023. Self-reported LARC use showed an upward trend, rising from 19.6% in 2018 to 31.0% in 2023. During the study period, the percentage of active duty women reporting same-sex relationships increased from 0.6% to 1.8%, but remained below 2%; abstinence increased from 0.3% to 2.8%, but remained below 3%; infertility increased from 8.0% to 9.0%; cycle tracking and family planning increased from 1.8% to 3.6%. Breastfeeding as a method to prevent pregnancy remained consistently low during the period of analysis, never exceeding 2.8% of responses. PHAs with free-text responses to ‘other’ contraceptive methods (n=1,713), which could not be classified into the categories described, were excluded from the analysis.

It is important to note that PHA data consist of self-reported physical health information and do not represent actual diagnoses, or prescriptions written, filled, or taken. Nevertheless, this information has value, providing insights into reproductive health trends affecting force readiness and resilience, for informed health care strategies.

Author Affiliations

Battelle Memorial Institute, supporting the Defense Centers for Public Health–Portsmouth, VA: Ms. Rodriguez, Ms. Gonzales; Defense Centers for Public Health–Portsmouth, EpiData Center, Defense Health Agency: Ms. Kelsey

Reference

  1. Department of Defense Forms Management Program. DD3024. Accessed Apr. 10, 2025. https://www.esd.whs.mil/directives/forms/dd3000_3499/dd3024

You also may be interested in...

Article
Feb 1, 2025

Surveillance Snapshot: Non-Hodgkin Lymphoma Incidence in Active Component U.S. Service Members, 2017–2023

This analysis utilizes an updated case definition for non-Hodgkin lymphoma developed by the Armed Forces Health Surveillance Division, based on consultation with subject matter experts and previous literature, to establish non-Hodgkin lymphoma incidence within the U.S. Armed Forces active component, from 2017 through 2023.

Article
Feb 1, 2025

External Cause Coding of Injury Encounters in the Military Health System Among Active Component U.S. Service Members, 2016–2019

Knowledge of injury causes is essential for prevention. This article describes causes of injury for all U.S. service members, from 2016 through 2019, and identifies variations in injury cause coding over time, and by branch of military service, type of health care visit and facility, and diagnosis category.

Article
Jan 1, 2025

Use of Positive Predictive Value to Evaluate the Armed Forces Health Surveillance Division Brain Cancer Incidence Rules, Active Component Department of the Air Force Pediatric Dependent Population, January 1, 2010–December 31, 2020

This study applied the Armed Forces Health Surveillance Division (AFHSD) case definition for the identification of malignant brain tumors among U.S. active service members to the dependent pediatric population of the active component of the U.S. Air Force, to determine the positive predictive value of this case definition for a pediatric population.

Article
Dec 1, 2024

Syphilis Cases Among Pregnant Women and Newborns in the Military Health System, 2012–2022

This report presents the rates of maternal syphilis among pregnant women and congenital syphilis among newborns in the Military Health System beneficiary population from 2012 to 2022. Between 2012 and 2021, cases of congenial syphilis in the U.S. increased by 755%, and rates of maternal and congenital syphilis within the Military Health System ...

Article
Dec 1, 2024

Post-Acute Sequelae of SARS-CoV-2 and Kidney Events in U.S. Active Component Service Members, March 1, 2020–September 30, 2022

This study assessed the incidence and incidence rate ratio of selected kidney events among U.S. active component service members that occurred from 31 days to six months after a COVID-19 test. Early evidence suggests that COVID-19 is linked to kidney-related events in older and hospitalized patients but has not been examined among a younger, healthy ...

Refine your search